China Pharma Holdings Inc
CPHI1.460USD
-0.180-10.98%
Market hours （ET）Quotes delayed by 15 min
476.24KMarket Cap
LossP/E TTM
More Details of China Pharma Holdings Inc Company
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
Company Info
Ticker SymbolCPHI
Company nameChina Pharma Holdings Inc
IPO dateFeb 15, 2000
CEOMs. Zhilin Li
Number of employees224
Security typeOrdinary Share
Fiscal year-endFeb 15
Address2nd Floor, No. 17, Jinpan Road
CityHAIKOU
Stock exchangeNYSE American Consolidated
CountryChina
Postal code570216
Phone8689866811730
Websitehttp://www.chinapharmaholdings.com
Ticker SymbolCPHI
IPO dateFeb 15, 2000
CEOMs. Zhilin Li
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
--
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
--
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
--
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
--
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
By BusinessUSD
Name
Revenue
Proportion
Domestic Pharmaceuticals
1.14M
0.00%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Domestic Pharmaceuticals
1.14M
0.00%
Shareholding Stats
Updated: Mon, Jun 2
Updated: Mon, Jun 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Li (Zhilin)
9.28%
Liu (Tao Chengdu)
9.20%
Streeterville Capital LLC
2.02%
Tsui (Heung Mei)
0.57%
UBS Financial Services, Inc.
0.32%
Other
78.61%
Shareholders
Shareholders
Proportion
Li (Zhilin)
9.28%
Liu (Tao Chengdu)
9.20%
Streeterville Capital LLC
2.02%
Tsui (Heung Mei)
0.57%
UBS Financial Services, Inc.
0.32%
Other
78.61%
Shareholder Types
Shareholders
Proportion
Individual Investor
19.05%
Corporation
2.02%
Investment Advisor
0.40%
Hedge Fund
0.38%
Venture Capital
0.26%
Other
77.90%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
18
721.01K
22.10%
+60.71K
2025Q1
21
1.02M
31.30%
+60.71K
2024Q4
21
10.05M
52.18%
+471.51K
2024Q3
20
9.91M
65.84%
+3.60M
2024Q2
20
9.93M
65.98%
+3.66M
2024Q1
18
9.99M
66.39%
+3.80M
2023Q4
16
6.74M
97.18%
+3.36M
2023Q3
16
3.69M
42.02%
+3.06M
2023Q2
16
907.22K
57.28%
+262.90K
2023Q1
16
923.80K
58.50%
+308.99K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Li (Zhilin)
302.76K
9.28%
--
--
Mar 24, 2025
Liu (Tao Chengdu)
300.00K
9.2%
--
--
Mar 24, 2025
Streeterville Capital LLC
65.84K
2.02%
+55.52K
+538.08%
Dec 31, 2023
Tsui (Heung Mei)
18.63K
0.57%
--
--
Mar 24, 2025
UBS Financial Services, Inc.
10.45K
0.32%
+7.30K
+231.58%
Mar 31, 2025
XTX Markets LLC
8.38K
0.26%
+1.67K
+24.84%
Mar 31, 2025
Citadel Advisors LLC
5.31K
0.16%
+5.31K
--
Mar 31, 2025
Renaissance Technologies LLC
4.61K
0.14%
+4.61K
--
Mar 31, 2025
Two Sigma Investments, LP
2.53K
0.08%
-4.45K
-63.71%
Mar 31, 2025
HRT Financial LP
2.51K
0.08%
+2.51K
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Dec 20, 2023
Merger
5<1
Dec 20, 2023
Merger
5<1
Dec 20, 2023
Merger
5<1
Dec 20, 2023
Merger
5<1
Feb 24, 2023
Merger
10<1
Feb 24, 2023
Merger
10<1
Date
Type
Ratio
Dec 20, 2023
Merger
5<1
Dec 20, 2023
Merger
5<1
Dec 20, 2023
Merger
5<1
Dec 20, 2023
Merger
5<1
Feb 24, 2023
Merger
10<1
Feb 24, 2023
Merger
10<1
Feb 24, 2023
Merger
10<1
Feb 24, 2023
Merger
10<1
